CVRX
CVRx IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$162.13M
P/E Ratio
—
EPS
$-2.01
Beta
0.87
52W High
$11.30
52W Low
$4.37
50-Day MA
$7.59
200-Day MA
$7.92
Dividend Yield
—
Profit Margin
-89.10%
Forward P/E
—
PEG Ratio
—
About CVRx Inc
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
Fundamentals
| Revenue (TTM) | $59.07M |
| Gross Profit (TTM) | $50.91M |
| EBITDA | $-49.21M |
| Operating Margin | -82.30% |
| Return on Equity | -107.00% |
| Return on Assets | -27.30% |
| Revenue/Share (TTM) | $2.25 |
| Book Value | $1.10 |
| Price-to-Book | 5.57 |
| Price-to-Sales (TTM) | 2.75 |
| EV/Revenue | 2.526 |
| EV/EBITDA | -1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 19.60% |
| Shares Outstanding | $26.54M |
| Float | $18.39M |
| % Insiders | 9.33% |
| % Institutions | 63.57% |
Historical Volatility
HV 10-Day
153.70%
HV 20-Day
122.77%
HV 30-Day
106.95%
HV 60-Day
88.14%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.17 target)
1
Strong Buy5
Buy1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026